undamentalytics Newsletter
Sign in

Pulse Biosciences, Inc. balance sheet

At the end of fiscal 2025, Pulse Biosciences, Inc. had total assets of $94.5m, total liabilities of $13.9m and shareholders' equity of $80.7m. It held $80.7m in cash against $0 of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents1244614411881102
Receivables—00—000
Inventory—60—000
Total current assets2245624511983106
Goodwill3333333
Total assets4159785913295116
Accounts payable2222233
Deferred revenue (current)—00————
Total current liabilities876710811
Long-term debt——650———
Total debt0—660000
Total liabilities18158015181416
Shareholders' equity2344−24411581100
Shares outstanding26m—37m55m66m68m71m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: IMDX vs PLSEICU vs PLSECODX vs PLSE

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pulse Biosciences, Inc.